JMP Securities Initiates Nuvation Bio(NUVB.US) With Buy Rating, Announces Target Price $6
Nuvation Bio Analyst Ratings
JMP Securities Initiates Coverage On Nuvation Bio With Market Outperform Rating, Announces Price Target of $6
Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE) and Nuvation Bio (NUVB)
JonesTrading Initiates Nuvation Bio(NUVB.US) With Buy Rating, Announces Target Price $10
Nuvation Bio Initiated at Buy by Jones Trading
Nuvation Bio Price Target Announced at $10.00/Share by Jones Trading
Nuvation Bio Analyst Ratings
H.C. Wainwright Maintains Nuvation Bio(NUVB.US) With Buy Rating, Cuts Target Price to $10
RBC Capital Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $10
TD Cowen Maintains Nuvation Bio(NUVB.US) With Buy Rating
Nuvation Bio Positioned for Growth: Buy Rating Affirmed on Strategic Moves and Promising Drug Pipeline
RBC Capital Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $10
RBC Capital Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $10
H.C. Wainwright Maintains Nuvation Bio(NUVB.US) With Buy Rating, Raises Target Price to $11
RBC Capital Maintains Nuvation Bio(NUVB.US) With Buy Rating, Raises Target Price to $10
Nuvation Bio Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Nuvation Bio, Maintains $7 Price Target
Buy Rating on Nuvation Bio: Promising Taletrectinib Results and Strong Valuation Support $7 Target
Nuvation Bio Is Maintained at Outperform by RBC Capital